info@seagull-health.com
SeagullHealth
语言:
search
new
Indications of ExtraSuperTadarise
504
Article source: Seagull Pharmacy
Sep 19, 2025

ExtraSuperTadarise is a combined preparation mainly used for the treatment of male erectile dysfunction (ED) and premature ejaculation (PE). As an enhanced formulation of Tadalafil, it combines the mechanisms of action of two active ingredients to provide a comprehensive treatment plan for male sexual dysfunction.

Indications of ExtraSuperTadarise

Main Therapeutic Uses

The main indication of ExtraSuperTadarise is the comprehensive treatment of male erectile dysfunction (ED) and premature ejaculation (PE).

Its core ingredient, Tadalafil, is a selective cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5) inhibitor, which improves erectile function by increasing blood flow to the penis.

Clinical studies have shown that Tadalafil can help men achieve and maintain a sufficient erection under sexual stimulation, with the therapeutic effect lasting for up to 36 hours.

Target Population

ED patients who have an inadequate response to monotherapy with PDE5 inhibitors.

Male patients with concurrent ED and PE symptoms.

Patients who desire a longer-lasting therapeutic effect.

Specifications and Properties of ExtraSuperTadarise

Dosage Form and Specifications

ExtraSuperTadarise is available as film-coated tablets.

Active Ingredients: Each tablet contains 20 mg of Tadalafil and 60 mg of Dapoxetine.

Tablet Appearance: Almond-shaped, with different color markings for different dosages.

Chemical Properties: The chemical name of Tadalafil is (6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione.

Composition

Active Ingredients: Tadalafil and Dapoxetine.

Excipients: Sodium croscarmellose, hydroxypropyl cellulose, hypromellose, iron oxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate, talc, titanium dioxide, triacetin, etc.

Storage Method of ExtraSuperTadarise

Storage Condition Requirements

Temperature Requirement: Store at 25°C (77°F); short-term exposure to a temperature range of 15-30°C (59-86°F) is allowed.

Packaging Requirement: Keep in the original packaging to protect from moisture.

Safety Requirement: Store out of the reach of children.

Precautions for Use

Administration Method: Take at most once a day, preferably approximately 1 hour before sexual activity.

Swallow Whole: The tablet should be swallowed whole; do not chew, crush, or split it.

Dietary Impact: It can be taken with or without food, but high-fat meals may delay drug absorption.

Missed Dose Handling: If a dose is missed, do not make up for it; take the next dose as scheduled.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
What Are the Side Effects of Etrasimod?
Etrasimod is a sphingosine-1-phosphate (S1P) receptor modulator indicated for the treatment of moderately to severely active ulcerative colitis (UC) in adults. It exerts its therapeutic effect by reve...
What Is the Therapeutic Efficacy of Etrasimod?
Etrasimod is a sphingosine 1-phosphate (S1P) receptor modulator. It was approved for marketing by the U.S. FDA in 2023 for the treatment of moderate to severe active ulcerative colitis (UC) in adults....
Etrasimod: Precautions and Monitoring for Medication Use
Etrasimod is a sphingosine 1-phosphate (S1P) receptor modulator indicated for the treatment of moderate to severe active ulcerative colitis (UC) in adults.Etrasimod: Precautions and Monitoring for Med...
Conventional Dosage and Administration
Etrasimod is a sphingosine 1-phosphate (S1P) receptor modulator indicated for the treatment of moderate to severe active ulcerative colitis (UC) in adults.How to Use EtrasimodConventional Dosage and A...
How to Use ExtraSuperTadarise
ExtraSuperTadarise is a combination preparation containing two active ingredients, Tadalafil and Dapoxetine. It is used for the treatment of male erectile dysfunction (ED) and premature ejaculation (P...
Precautions for Administration of ExtraSuperTadarise
ExtraSuperTadarise is a combined preparation, whose main ingredients are Tadalafil and Dapoxetine. It is used for the treatment of male erectile dysfunction (ED) and premature ejaculation (PE).Precaut...
What Is the Therapeutic Efficacy of ExtraSuperTadarise?
ExtraSuperTadarise is a combined preparation whose main ingredients include Tadalafil and Dapoxetine. It is used for the treatment of male erectile dysfunction (ED) and premature ejaculation (PE).What...
What are the side effects of ExtraSuperTadarise?
ExtraSuperTadarise is a combined preparation, whose main ingredients include Tadalafil and Dapoxetine. It is used for the treatment of male Erectile Dysfunction (ED) and Premature Ejaculation (PE). Ta...
Related Articles
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
Adverse Reactions of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma...
What Are the Precautions for Using Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy medication primarily indicated for the treatment of patients with malignant hematologic diseases harboring specific gene mutations.What Are the Precautions f...
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved